We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Irvine Scientific Introduces PRIME-XV T Cell CDM for Immunotherapy Applications

Product News   Jan 18, 2017 | Original story from Irvine Scientific

 
Irvine Scientific Introduces PRIME-XV T Cell CDM for Immunotherapy Applications
FURTHER INFORMATION
 
 
 

Related Product News

Engineering Antibodies Against Animal Venom Toxins

Product News

Absolute Antibody Ltd. has announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venoms.

READ MORE

Arbor Biosciences Offers Novel 2019 Coronavirus Panel for Free to Research Community

Product News

Arbor Biosciences has announced the release of a myBaits Expert hybridization-based panel for the 2019 Novel Coronavirus (2019-nCoV), free of charge to researchers.

READ MORE

The Native Antigen Company Introduces Novel Coronavirus Antigens

Product News

The Native Antigen Company has announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain.

READ MORE

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE